These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38841696)

  • 21. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
    Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercoagulation on Thromboelastography Predicts Early Neurological Deterioration in Patients with Acute Ischemic Stroke.
    Shi Z; Zheng WC; Fu XL; Fang XW; Xia PS; Yuan WJ
    Cerebrovasc Dis; 2018; 46(3-4):125-131. PubMed ID: 30199865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke.
    Geng HH; Wang Q; Li B; Cui BB; Jin YP; Fu RL; Zhang Q; Wang JJ; Wang PX
    Medicine (Baltimore); 2017 Dec; 96(51):e9068. PubMed ID: 29390435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High or increasing serum NfL is predictive of impending multiple sclerosis relapses.
    Thebault S; Reaume M; Marrie RA; Marriott JJ; Furlan R; Laroni A; Booth RA; Uccelli A; Freedman MS
    Mult Scler Relat Disord; 2022 Mar; 59():103535. PubMed ID: 35078125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
    Meier S; Willemse EAJ; Schaedelin S; Oechtering J; Lorscheider J; Melie-Garcia L; Cagol A; Barakovic M; Galbusera R; Subramaniam S; Barro C; Abdelhak A; Thebault S; Achtnichts L; Lalive P; Müller S; Pot C; Salmen A; Disanto G; Zecca C; D'Souza M; Orleth A; Khalil M; Buchmann A; Du Pasquier R; Yaldizli Ö; Derfuss T; Berger K; Hermesdorf M; Wiendl H; Piehl F; Battaglini M; Fischer U; Kappos L; Gobbi C; Granziera C; Bridel C; Leppert D; Maleska Maceski A; Benkert P; Kuhle J
    JAMA Neurol; 2023 Mar; 80(3):287-297. PubMed ID: 36745446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of glycosylated hemoglobin on early neurological deterioration in acute mild ischemic stroke patients treated with intravenous thrombolysis.
    Han L; Hou Z; Ma M; Ding D; Wang D; Fang Q
    Front Aging Neurosci; 2022; 14():1073267. PubMed ID: 36711206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low T
    Wang Y; Zhou S; Bao J; Pan S; Zhang X
    Int J Neurosci; 2017 Jul; 127(7):559-566. PubMed ID: 27401927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort.
    Steffen F; Uphaus T; Ripfel N; Fleischer V; Schraad M; Gonzalez-Escamilla G; Engel S; Groppa S; Zipp F; Bittner S
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36411080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke.
    Choi JC; Kim BJ; Han MK; Lee SJ; Kang K; Park JM; Park SS; Park TH; Cho YJ; Hong KS; Lee KB; Lee J; Ryu WS; Kim DE; Nah HW; Kim DH; Cha JK; Kim JT; Choi KH; Oh MS; Yu KH; Lee BC; Jang MS; Lee JS; Lee J; Bae HJ;
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1306-1313. PubMed ID: 28318959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
    Thouvenot E; Demattei C; Lehmann S; Maceski-Maleska A; Hirtz C; Juntas-Morales R; Pageot N; Esselin F; Alphandéry S; Vincent T; Camu W
    Eur J Neurol; 2020 Feb; 27(2):251-257. PubMed ID: 31437330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and Outcomes of Intravenous Thrombolysis in Mild Ischemic Stroke Patients.
    Tang H; Yan S; Wu C; Zhang Y
    Front Neurol; 2021; 12():744909. PubMed ID: 34777212
    [No Abstract]   [Full Text] [Related]  

  • 32. Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study.
    Hegen H; Berek K; Bsteh G; Auer M; Altmann P; Di Pauli F; Grams A; Milosavljevic D; Ponleitner M; Poskaite P; Schnabl C; Wurth S; Zinganell A; Berger T; Walde J; Deisenhammer F
    EBioMedicine; 2023 May; 91():104573. PubMed ID: 37086651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease.
    Ziemssen T; Smolinski L; Członkowska A; Akgun K; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Redzia-Ogrodnik B; Litwin T
    Acta Neurol Belg; 2023 Jun; 123(3):917-925. PubMed ID: 36098934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.
    Verde F; Milone I; Bulgarelli I; Peverelli S; Colombrita C; Maranzano A; Calcagno N; Ticozzi N; Perego GB; Parati G; Torresani E; Ratti A; Silani V
    J Neurol; 2022 Nov; 269(11):5691-5701. PubMed ID: 35781535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years.
    Cantó E; Barro C; Zhao C; Caillier SJ; Michalak Z; Bove R; Tomic D; Santaniello A; Häring DA; Hollenbach J; Henry RG; Cree BAC; Kappos L; Leppert D; Hauser SL; Benkert P; Oksenberg JR; Kuhle J
    JAMA Neurol; 2019 Nov; 76(11):1359-1366. PubMed ID: 31403661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
    Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
    Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome.
    Rival M; Thouvenot E; Du Trieu de Terdonck L; Laurent-Chabalier S; Demattei C; Uygunoglu U; Castelnovo G; Cohen M; Okuda DT; Kantarci OH; Pelletier D; Azevedo C; Marin P; Lehmann S; Siva A; Mura T; Lebrun-Frenay C;
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36280258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory.
    Bang OY; Park HY; Yoon JH; Yeo SH; Kim JW; Lee MA; Park MH; Lee PH; Joo IS; Huh K
    J Clin Neurol; 2005 Oct; 1(2):148-58. PubMed ID: 20396462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum neurofilament light chain levels are associated with stroke severity and functional outcome in patients undergoing endovascular therapy for large vessel occlusion.
    Rahmig J; Akgün K; Simon E; Gawlitza M; Hartmann C; Siepmann T; Pallesen LP; Barlinn J; Puetz V; Ziemssen T; Barlinn K
    J Neurol Sci; 2021 Oct; 429():118063. PubMed ID: 34488043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.